10 results
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Summary of Diuretic ... Agents Subclass, Drug ... #Medications #Pharmacology ... #summary #table ... #nephrology
Pharmacokinetics of commonly used diuretics medications in CKD, Cirrhotic Ascites, and Heart Failure
 • Furosemide
 •
commonly used diuretics ... medications in ... Spironolactone MCW Nephrology ... #pharmacology # ... halflife #comparison #table
Immunosuppression in Transplantation
Induction (I):
 - Basiliximab (Simulect)
 - Alemtuzumab (Campath)
 - Rituximab
 - Anti-Thymocyte Globulin (ATG)
Induction
Transplantation Induction ... Immunosuppressive #Medications ... #Pharmacology # ... Table #Drugs #Induction ... Maintenance #Management #Nephrology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Diuretics and Agents ... Symport (Loop Diuretics ... ; High-Ceiling Diuretics ... #Nephrology #Pharmacology ... #Medications #Table
Rhabdomyolysis - Differential Diagnosis Framework and Management Summary

Causes of Rhabdomyolysis:
 • Trauma:
	- Immobilization
	- Crush injury
	- Compartment
- Toxins - Drugs ... : • Triad of symptoms ... urine • Other symptoms ... Loop diuretics for ... causes #treatment #nephrology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Syndrome (PRES) Overview ... Neurological symptoms ... Electrolyte abnormality, Medication ... /Drug toxicity, ... diagnosis #management #neurology
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Myasthenia Gravis Overview ... test - Cogan sign ... - Peek sign ... precipitated by: Drugs ... diagnosis #management #neurology
Aimovig (Erenumab)
Mechanism: Calcitonin Gene-related Peptide Receptor Antagonist 
Indication: Preventive Treatment of Migraines:
Dosing: 70 mg SQ monthly,
Receptor Antagonist Indication ... reported this drug ... effects being injection ... Erenumab #Migraine #Neurology ... #Pharmacology #
Transverse Myelitis Overview

Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
Transverse Myelitis Overview ... Direct microbial infection ... • Bilateral signs ... and/or symptoms ... diagnosis #management #neurology
Headaches Overview - Primary vs Secondary Headaches

What’s the Core Difference?
 • Primary headache = headache is
Headaches Overview ... headache is a symptom ... N Neurological signs ... confusion, focal signs ... Secondary #Comparison #Neurology